News Go

News & articles

Pharmacists warn of medicine scarcity in Sudan – Sudan

While medicine prices increase, some life-saving medicines have become scarce in Khartoum and other states. Patients and their attendants complained that medicines have become unaffordable.

Some medicines prices have exceeded the price issued that the board of medicines issues in 2016, pharmacist Awad Mohamed said. “The price of Atakat tablets for blood pressure has risen from SDG 280 ($41.70) to SDG 418 ($62.30). The price for one of the categories of diabetes drugs has risen from SDG 550 ($82) to SDG 1037 ($154.60).”

A number of companies stopped selling medicines altogether because of the instability of the exchange rate of the Dollar. “This caused the scarcity of medicines such as asthma sprays, aspirin, as well as medicine against prostate diseases and medical treatment for psychiatric disorders.”

The pharmacist said that the Sudanese government is not committed to its promises to provide the Dollar at the official exchange rate for the import of life-saving medicines and medicines for children under the age of five.

He attributed the steady increase in the prices of medicines to the economic decisions taken by the Sudanese government in 2016. “They raised the import prices for medicines to SDG 15 ($2.20) instead of SDG 6.9 ($1). In addition the pharmaceutical companies have resorted to buying US Dollars from the parallel market.”

Mohamed warned for the serious effects of the high prices of medicines for chronic diseases such as diabetes and blood pressure. “Patients with a low income have stopped buying medicines and resorted to herbs.”


The deputy chairman of the health committee in the Sudanese parliament, Saleh Jumaa, said that the prices of medicines have risen by 200 percent in hospitals and pharmacies.

Jumaa expected a deepening shortage of medicines and increasing prices in the coming period. The Central Bank of Sudan is not committed to paying the debts on medical supplies by external companies, he…

Read the full article from the Source…

Back to Top